Oncology

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

Research Summary
Physician writing
Research Summary
PFS Shows Moderate Correlation With OS but Limited Surrogacy in Phase 3 Mantle Cell Lymphoma Trials
06/19/2026
Ashton L. Stahl
A phase 3 trial-level analysis evaluated whether PFS reliably predicts OS in mantle cell lymphoma.
06/19/2026
Research Summary
AI image
Research Summary
Patient-Facing AI Cancer Care Information Often Difficult to Read, Low Quality
06/18/2026
Ashton L. Stahl
A cross-sectional analysis of Google webpages and YouTube videos evaluates readability and quality of patient-facing AI cancer care content.
06/18/2026
What's Your Diagnosis?
A presentation of right axillary mass is shown.
What's Your Diagnosis?
An 84-Year-Old Man With an Axillary Mass
06/14/2026
Michael Grover, DO
An 84-year-old man presented to primary care with a progressively enlarging, nontender right axillary mass.
06/14/2026

Interactive Features

Pop Quiz
doctor pointing at image of lung
Pop Quiz
Does Shared Decision-Making Improve Long-Term Lung Cancer Screening Adherence?
05/07/2026
Kate Young
SDM visits are a cornerstone of Medicare-covered lung cancer screening—but do you know how they influence whether patients return year after year? Take this brief quiz to test your knowledge!
05/07/2026
Pop Quiz
Stethoscope image
Pop Quiz
Prior Adenoma and Colorectal Cancer Risk in Older Adults
04/22/2026
Ashton L. Stahl
How much does a prior adenoma matter after age 75? Test your understanding of CRC risk vs competing mortality.
04/22/2026
Quiz Series
patient in hospital bed
Quiz Series
Evolving Patterns of Neoadjuvant Systemic Therapy in US Cancer Care
03/05/2026
Anthony Calabro, MA
Trends from the National Cancer Database show that the use of neoadjuvant systemic therapy (NST) has increased sharply over the past decade but not uniformly across cancer types or stages. Test your...
03/05/2026
Slideshow
doctor with headphones at her laptop
Slideshow
Top 5 Podcast Episodes of 2025
12/23/2025
Kate Young
This year we’ve explored critical clinical insights, cutting-edge care strategies, and expert perspectives on our podcast. Today, we’re excited to count down the five standout podcast episodes that...
12/23/2025
Pop Quiz
physician at desk
Pop Quiz
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
12/17/2025
Ashton L. Stahl
As researchers continue exploring early-intervention strategies for high-risk smoldering multiple myeloma, understanding the basic pathophysiology of plasma cell disorders (and the targets of emerging...
12/17/2025

Clinical Insights

Sponsored
Tim F.
Sponsored
Myelofibrosis Caregiver Interview Series: The Impact of Myelofibrosis on Caregivers
05/18/2026
In the latest installment of the Myelofibrosis Caregiver Interview Series, Tim F. from Pittsburgh, PA, talks with Fadi Haddad, MD about the caregiver perspective, highlighting the substantial day-to-day...
05/18/2026
Sponsored
Tim F. and Fadi Haddad, MD
Sponsored
Myelofibrosis Caregiver Interview Series: Monitoring Myelofibrosis Treatment Effectiveness
04/21/2026
Fadi G. Haddad, MD
Monitoring treatment response in myelofibrosis requires a balanced assessment of patient-reported symptoms, objective scoring tools, hematologic parameters, and spleen size. In part 1 of this Myelofibrosis...
04/21/2026
Video
Brian M. Slomovitz, MD
Video
Investigating Immunotherapy and Chemotherapy in Endometrial Cancer Outcomes
03/03/2026
Brian M. Slomovitz, MD
In this video, Brian M. Slomovitz, MD, discusses his recent study demonstrating a significant improvement in disease-free survival with pembrolizumab in patients with dMMR endometrial cancer. He explains...
03/03/2026
Expert Q&A
Brady L Stein, MD
Expert Q&A
How the ASH Clinical Practice Guidelines Aim to Improve Myelofibrosis Management
12/22/2025
Brady L. Stein, MD
At the 2025 American Society of Hematology (ASH) Annual Meeting, Brady Stein, MD, chaired a session introducing the forthcoming ASH Clinical Practice Guidelines on Myelofibrosis—the first ASH-supported...
12/22/2025
Expert Q&A
Daniel Lenihan, MD, FACC, FESC, FIC-OS
Expert Q&A
Multidisciplinary Management of Cardiovascular Risk in Patients With CLL on BTK Inhibitors
11/04/2025
Daniel Lenihan, MD, FACC, FESC
Daniel Lenihan, MD, FACC, FESC, FIC-OS, a cardio-oncologist and founder of the International Cardio-Oncology Society, discusses cardiovascular risks associated with Bruton's tyrosine kinase inhibitors in...
11/04/2025